Receptor for Advanced Glycation End Products: Dementia and Cognitive Impairment
- PMID: 36889338
- DOI: 10.1055/a-2015-8041
Receptor for Advanced Glycation End Products: Dementia and Cognitive Impairment
Abstract
The pathophysiological processes of dementia and cognitive impairment are linked to advanced glycation end products (AGEs) and their receptor (RAGE).The neurofibrillary tangles (NFTs) of abnormally hyperphosphorylated tau protein and senile plaques (SPs), which are brought on by amyloid beta (Aβ) deposition, are the hallmarks of Alzheimer's disease (AD), a progressive neurodegenerative condition. Advanced glycation end products that are produced as a result of vascular dysfunction are bound by the receptor for advanced glycation end products (RAGE). Dementia and cognitive impairment could develop when RAGE binds to Aβ and produces reactive oxygen species, aggravating Aβ buildup and ultimately resulting in SPs and NFTs. RAGE could be a more powerful biomarker than Aβ because it is implicated in early AD. The resident immune cells in the brain known as microglia are essential for healthy brain function. Microglia is prominent in the amyloid plaques' outside border as well as their central region in Alzheimer's disease. Microglial cells, in the opinion of some authors, actively contribute to the formation of amyloid plaques. In this review, we first discuss the early diagnosis of dementia and cognitive impairment, and then detail the interaction between RAGE and Aβ and Tau that is necessary to cause dementia and cognitive impairment pathology, and it is anticipated that the creation of RAGE probes will help in the diagnosis and treatment of dementia and cognitive impairment.
Thieme. All rights reserved.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare no conflict of interest among themselves. The authors alone are responsible for the content and writing of this article.
Similar articles
-
AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.Mol Cell Biochem. 2019 Sep;459(1-2):95-112. doi: 10.1007/s11010-019-03553-4. Epub 2019 May 11. Mol Cell Biochem. 2019. PMID: 31079281 Review.
-
Role of RAGE in Alzheimer's Disease.Cell Mol Neurobiol. 2016 May;36(4):483-95. doi: 10.1007/s10571-015-0233-3. Epub 2015 Jul 15. Cell Mol Neurobiol. 2016. PMID: 26175217 Review.
-
Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.J Biol Chem. 2018 Jan 5;293(1):226-244. doi: 10.1074/jbc.M117.786756. Epub 2017 Nov 10. J Biol Chem. 2018. PMID: 29127203 Free PMC article.
-
Progress of RAGE Molecular Imaging in Alzheimer's Disease.Front Aging Neurosci. 2020 Aug 4;12:227. doi: 10.3389/fnagi.2020.00227. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32848706 Free PMC article. Review.
-
Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.Hypertension. 2012 Jul;60(1):188-97. doi: 10.1161/HYPERTENSIONAHA.112.195511. Epub 2012 May 21. Hypertension. 2012. PMID: 22615109 Free PMC article.
Cited by
-
SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system.Transl Neurodegener. 2024 Aug 9;13(1):41. doi: 10.1186/s40035-024-00431-y. Transl Neurodegener. 2024. PMID: 39123214 Free PMC article. Review.
-
The Effects of Dietary Intervention and Macrophage-Activating Factor Supplementation on Cognitive Function in Elderly Users of Outpatient Rehabilitation.Nutrients. 2024 Jun 28;16(13):2078. doi: 10.3390/nu16132078. Nutrients. 2024. PMID: 38999825 Free PMC article. Clinical Trial.
-
A Review on Tau Targeting Biomimetics Nano Formulations: Novel Approach for Targeting Alzheimer's Diseases.Cent Nerv Syst Agents Med Chem. 2024;24(3):294-303. doi: 10.2174/0118715249289120240321065936. Cent Nerv Syst Agents Med Chem. 2024. PMID: 38646682 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical